Today: 20 May 2026
Guidewire stock sinks 6.7%: GWRE slides below $190 as traders eye next earnings
4 January 2026
2 mins read

Guidewire stock sinks 6.7%: GWRE slides below $190 as traders eye next earnings

New York, January 3, 2026, 20:07 ET — Market closed

  • Guidewire Software shares fell 6.7% in Friday’s session, ending at $187.63.
  • The move left the stock sharply lower from the $200 area after an early-session rally faded.
  • Investors are now focused on ARR growth and the next quarterly update as the next catalyst.

Shares of Guidewire Software fell 6.7% on Friday to $187.63, after swinging between $187.10 and $202.00 in the session. About 807,000 shares changed hands.

The drop matters because Guidewire is a widely followed bet on insurers’ shift to cloud-based core systems, a transition investors have treated as a multi-year growth story. Rate expectations still loom over growth stocks, and sharp moves can follow when investors reassess how much they want to pay for earnings expected further out.

For Guidewire, the focus is its shift from license sales to cloud subscriptions. Investors track annual recurring revenue (ARR) — the annualized value of contracted subscription and support fees — for a read on whether demand is still building.

The broader tech backdrop was steadier. The Nasdaq-100 tracking fund QQQ slipped 0.2% in Friday’s session, while the Technology Select Sector SPDR ETF XLK rose about 0.2%.

Guidewire sells software used by property-and-casualty insurers to run policy, billing and claims operations. Its cloud platform is designed to replace legacy systems and generate recurring subscription fees.

In its most recent quarterly report on Dec. 3, Guidewire said total revenue rose 27% from a year earlier to $332.6 million, helped by a 31% jump in subscription and support revenue to $222.2 million. Annual recurring revenue stood at $1.063 billion at Oct. 31 and the company raised its fiscal 2026 outlook to total revenue of $1.403 billion to $1.419 billion, after unveiling new pricing and underwriting products at its Connections customer conference. “ARR growth of 22% year-over-year reflects the strong sales momentum we have established,” Chief Financial Officer Jeff Cooper said. Guidewire

ARR is not the same as recognized revenue, but it is often used as a shorthand for the scale of recurring contract value at quarter-end. Investors will also watch whether subscription margins and cash generation improve as services work scales.

Guidewire said in October it agreed to buy ProNavigator, a knowledge management platform used by 34 insurance organizations, and expects the deal to close in its fiscal second quarter, subject to customary conditions. The company said the purchase would let it embed context-aware knowledge directly into underwriting, claims and distribution workflows.

The deal adds another layer to Guidewire’s platform strategy, but investors also tend to scrutinize execution risks in insurance technology, where implementations can be complex and timelines matter. Those issues can surface first in cloud bookings and renewals, even if reported revenue lags.

Before Monday’s reopen, traders will watch whether GWRE can hold above the $187 area after Friday’s steep drop. A rebound through $200–$202 would push the stock back toward the zone it traded earlier in the session.

The next scheduled catalyst is Guidewire’s fiscal second-quarter results, due March 5, according to Investing.com’s earnings calendar. Investors will be watching for ARR growth, subscription revenue and any adjustment to the full-year outlook.

With the stock now showing wider day-to-day swings, short-term positioning can amplify moves when U.S. trading resumes. For longer-term holders, the pace of cloud migrations and uptake of the company’s newer pricing and underwriting products are likely to stay at the center of the debate.

Stock Market Today

  • Asia Stocks Fall as Tech Sector Drag; KOSPI Down on Samsung Union Strike Plans
    May 19, 2026, 11:47 PM EDT. Asian stock markets fell sharply, driven by losses in the technology sector. South Korea's KOSPI index led declines as Samsung Electronics faces a planned strike by its union, raising concerns over potential disruptions. Investors remain wary as labor unrest affects a key global tech supplier, intensifying pressure on regional equities.

Latest articles

Wall Street Hit by Yield Jolt With Nvidia Up Next

Wall Street Hit by Yield Jolt With Nvidia Up Next

20 May 2026
U.S. stock ETFs remained lower late Tuesday after Wall Street’s main indexes fell for a third straight session, pressured by rising Treasury yields and caution ahead of Nvidia’s earnings. The SPDR S&P 500 ETF dropped 0.7% to $733.73. The 10-year Treasury yield hit 4.687%, its highest since January 2025, before easing. Nvidia shares slipped 0.7% after hours, with traders bracing for a major move post-earnings.
Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

Viavi Stock Drops After $500 Million Share Sale Plan — The Debt Move Investors Can’t Ignore

20 May 2026
Viavi Solutions shares dropped 7.1% in after-hours trading Tuesday after the company announced a $500 million public stock offering aimed at repaying debt. The offering, unveiled just after the Nasdaq close, could add roughly 10.1 million new shares. Viavi plans to use proceeds to pay down a $450 million loan. Total debt would fall to $650 million, according to a preliminary SEC filing.
Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

Analog Devices Shares Rally After $1.5B AI Power Deal Ahead of Earnings

20 May 2026
Analog Devices agreed to acquire Empower Semiconductor for $1.5 billion in cash, sending ADI shares up 1.36% to $419.95 in after-hours trading after closing down 1.02%. The deal, approved by both boards, is expected to close in the second half of 2026 pending regulatory review. Empower CEO Tim Phillips will continue to lead integrated voltage regulator work after the merger.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds
Next Story

Baidu stock today: BIDU jumps on Kunlunxin Hong Kong IPO plan as AI-chip frenzy builds

Go toTop